Last Updated: 10 Nov 2024
Executive Summary
ASP Isotopes Inc. (ASPI) is a life sciences company with a focus on miscellaneous chemical products. Despite a challenging financial performance marked by negative earnings and profitability metrics, the company has a modest market capitalization of $624.1 million. Analyst sentiment is cautiously optimistic, with one analyst rating the stock a "Buy." The latest stock price of $8.77 is within the 52-week trading range of $1.45 to $9.23.
Company Overview
ASP Isotopes invests, develops, remodels, and manages a portfolio of multi-family properties in metropolitan areas of the United States. The company's headquarters are in Irvine, California.
Fundamental Analysis
Revenue: $22.96 million TTM
EBITDA: -$20.95 million
Net Income: -$43.86 million TTM
EPS: -$0.62 TTM
Book Value: $0.211
ASP Isotopes has reported consecutive quarters of negative earnings and profitability. The company's revenue growth is stagnant, and its profit margin is zero. The negative return on assets and equity highlight the company's current financial challenges.
Technical Analysis
52-Week High: $9.23
52-Week Low: $1.45
50-Day Moving Average: $3.888
200-Day Moving Average: $3.532
The stock price has been trading above its moving averages in recent months, indicating a potential bullish trend. However, the stock remains well below its 52-week high.
Short Term Outlook
The company's financial performance remains a concern. Analysts expect the company to continue to report negative earnings in the near term. The stock price may face resistance at its current levels.
Long Term Outlook
ASP Isotopes has a potential growth opportunity in the life sciences sector. However, the company needs to improve its financial performance to attract investors.
Analyst Recommendations
One analyst has rated ASP Isotopes a "Buy" with a target price of $6.5. This target price implies a potential upside of approximately 23% from the current stock price.
Disclaimer: This report is for informational purposes only and should not be considered investment advice.
